Bayer Head of Pharma, Stefan Oelrich, at the 10/24 World Health Summit on Capitalizing on the Momentum of Innovation from COVID-19 “I always like to say, if we had surveyed 2 years ago in the public, would you be willing to take gene or cell therapy and inject it into your body, we would have probably had a 95% refusal rate”